Categories
AFNewsNG Logo
Health Special Report

US Approves hydroxychloroquine sulphate For Treating Coronavirus

chuks oti

Mar 30, 2020

The Food and Drug Administration on Sunday (FDA) issued an emergency-use authorization for a pair of anti-malaria drugs as health officials work to combat the rapid spread of the novel coronavirus.

READ ALSO: How a Nigerian Professor's AI System Could Predict Depression Before Symptoms Emerge

The Health and Human Services Department (HHS) said in a statement that the authorization would allow 30 million doses of hydroxychloroquine sulfate and 1 million doses of chloroquine phosphate to be donated to the Strategic National Stockpile. The doses of hydroxychloroquine sulfate were donated by Sandoz, while the chloroquine phosphate was developed by Bayer Pharmaceuticals.

READ ALSO: Nigeria Air Force clarifies portal for NAF recruitment 2020

The products will be "((distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible))," HHS said.

READ ALSO: Abia Youths Demand Free, Fair Election, Storm INEC Headquarters In Umuahia | WATCH VIDEO

READ ALSO:JUST IN: Nigeria Records Second Death From Coronavirus

READ ALSO: Why Nigeria Must Declare a State of Emergency on Malaria - Hon. Amobi Ogah Reveals at National Retreat

President Trump has repeatedly touted the anti-malaria drugs as a possible coronavirus "game changer," despite warnings from health officials that not enough is known about their effects on COVID-19. Dr. Anthony Fauci, the government's top infectious disease expert, said during a press briefing earlier this month that much of what is known about the drug is based on "anecdotal reports."

READ ALSO: 'Buhari Died In London Hospital After Promising Nigerians Quality Healthcare' - Activist Adetoun Attacks Late Ex President

Credits

Related Stories

""

— chuks oti

Join the Conversation

Signed in as Member